Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Slingluff

Showing results (161-170 of 226) with videos related to

Pageof 23
Sort By:
Oncotarget|March 7, 2018
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancerKiley A Knapp, Eusebio S Pires, Sara J Adair, et al.
The Journal of Surgical Research|January 22, 2023
Evaluation of Preoperative and Intraoperative Mobile Gamma Camera Imaging in Sentinel Lymph Node Biopsy for Melanoma Independent of Preoperative LymphoscintigraphyJoshua M Judge, Kosta Popovic, Gina R Petroni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2021
Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor LocationPaul R Kunk, Sean C Dougherty, Kevin Lynch, et al.
Oncoimmunology|January 27, 2017
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality riskElise P Salerno, Davide Bedognetti, Ileana S Mauldin, et al.
Annals of Surgical Oncology|May 17, 2017
Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter StudyGeorgia M Beasley, Yinin Hu, Linda Youngwirth, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccineElizabeth M H Woodson, Kimberly A Chianese-Bullock, Catherine J Wiernasz, et al.
Science (New York, N.Y.)|September 14, 2002
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Jeffrey R Lee, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2021
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trialsMarit M Melssen, Karlyn E Pollack, Max O Meneveau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanomaGalina V Yamshchikov, David W Mullins, Chien-Chung Chang, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonistMax O Meneveau, Gina R Petroni, Elise P Salerno, et al.
Pageof 23

Showing results (161-170 of 226) with videos related to

Sort By:
Pageof 23
Oncotarget|March 7, 2018
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancerKiley A Knapp, Eusebio S Pires, Sara J Adair, et al.
The Journal of Surgical Research|January 22, 2023
Evaluation of Preoperative and Intraoperative Mobile Gamma Camera Imaging in Sentinel Lymph Node Biopsy for Melanoma Independent of Preoperative LymphoscintigraphyJoshua M Judge, Kosta Popovic, Gina R Petroni, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2021
Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor LocationPaul R Kunk, Sean C Dougherty, Kevin Lynch, et al.
Oncoimmunology|January 27, 2017
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality riskElise P Salerno, Davide Bedognetti, Ileana S Mauldin, et al.
Annals of Surgical Oncology|May 17, 2017
Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter StudyGeorgia M Beasley, Yinin Hu, Linda Youngwirth, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccineElizabeth M H Woodson, Kimberly A Chianese-Bullock, Catherine J Wiernasz, et al.
Science (New York, N.Y.)|September 14, 2002
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Jeffrey R Lee, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2021
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trialsMarit M Melssen, Karlyn E Pollack, Max O Meneveau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanomaGalina V Yamshchikov, David W Mullins, Chien-Chung Chang, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonistMax O Meneveau, Gina R Petroni, Elise P Salerno, et al.
Pageof 23